Preferred Label : Stage IIA Lung Squamous Cell Carcinoma AJCC v7;
NCIt synonyms : Stage IIA Squamous Cell Carcinoma of Lung; Stage IIA Squamous Cell Carcinoma of the Lung; Stage IIA Squamous Cell Lung Carcinoma; Stage IIA Squamous Cell Lung Carcinoma AJCC v7;
NCIt related terms : Stage IIA Squamous Cell Lung Cancer;
NCIt definition : Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0). T2b:
Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.
T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded
by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal
than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial
tumor of any size with its invasive component limited to the bronchial wall, which
may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer
with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded
by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal
than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a
tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional
lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial
and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement
by direct extension. M0: No distant metastasis. (AJCC 7th ed.);
Neoplastic status : Malignant;
Origin ID : C6688;
UMLS CUI : C1336173;
Disease excludes abnormal cell
- Disease may have findings
- Excludes anatomical site(s)
- Has associated anatomic sites
- Semantic type(s)
- concept_is_in_subset
- disease_excludes_finding
- disease_has_abnormal_cell
- disease_has_finding
- disease_has_normal_cell_origin
- disease_has_normal_tissue_origin
- disease_has_primary_anatomic_site
- disease_is_stage
- disease_mapped_to_gene
- disease_may_have_cytogenetic_abnormality
- disease_may_have_molecular_abnormality
